Corient Private Wealth LP Invests $2.70 Million in Molina Healthcare, Inc $MOH

Corient Private Wealth LP purchased a new stake in Molina Healthcare, Inc (NYSE:MOH) in the second quarter, Holdings Channel reports. The firm purchased 11,823 shares of the company’s stock, valued at approximately $2,704,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Elevation Wealth Partners LLC lifted its position in Molina Healthcare by 118.2% during the second quarter. Elevation Wealth Partners LLC now owns 144 shares of the company’s stock worth $33,000 after buying an additional 78 shares in the last quarter. MUFG Securities EMEA plc purchased a new stake in Molina Healthcare in the 2nd quarter valued at $48,000. Global Retirement Partners LLC acquired a new stake in shares of Molina Healthcare in the 2nd quarter worth $39,000. Quarry LP purchased a new position in shares of Molina Healthcare during the 4th quarter worth $32,000. Finally, Triumph Capital Management boosted its position in shares of Molina Healthcare by 4,625.0% during the 4th quarter. Triumph Capital Management now owns 189 shares of the company’s stock valued at $33,000 after acquiring an additional 185 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Stock Performance

NYSE:MOH opened at $203.43 on Wednesday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.68 and a current ratio of 1.68. The stock has a market capitalization of $10.62 billion, a P/E ratio of -1,130.10, a PEG ratio of 28.49 and a beta of 0.75. The company has a 50 day moving average price of $211.65 and a 200 day moving average price of $181.09. Molina Healthcare, Inc has a fifty-two week low of $121.06 and a fifty-two week high of $244.89.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Wednesday, July 22nd. The company reported $1.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.12. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%.The company had revenue of $10.87 billion for the quarter, compared to analyst estimates of $10.83 billion. During the same quarter in the previous year, the company earned $5.48 earnings per share. The firm’s quarterly revenue was down 4.8% compared to the same quarter last year. Equities research analysts forecast that Molina Healthcare, Inc will post 5.29 EPS for the current year.

Analysts Set New Price Targets

Several research firms recently issued reports on MOH. Royal Bank Of Canada cut their price objective on shares of Molina Healthcare from $248.00 to $218.00 and set a “sector perform” rating for the company in a research report on Friday, July 24th. Robert W. Baird raised their price target on shares of Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. Truist Financial cut their price target on shares of Molina Healthcare from $250.00 to $225.00 and set a “hold” rating for the company in a report on Friday, July 24th. Wall Street Zen cut Molina Healthcare from a “hold” rating to a “sell” rating in a report on Saturday. Finally, Cantor Fitzgerald reiterated a “neutral” rating on shares of Molina Healthcare in a research report on Friday, July 24th. Three equities research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $202.44.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.